Your browser doesn't support javascript.
loading
The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey.
Bulur, Isil; Bulbul Baskan, Emel; Ozdemir, Mustafa; Balevi, Ali; Kocatürk Göncü, Emek; Altunay, Ilknur; Gönül, Müzeyyen; Ergin, Can; Ertam, Ilgen; Erdogan, Hilal Kaya; Bilgin, Muzaffer; Mustafa Teoman, Erdem.
Afiliación
  • Bulur I; Department of Dermatology, Faculty of Medicine, Maltepe University, Istanbul, Turkey.
  • Bulbul Baskan E; Department of Dermatology, Faculty of Medicine, Uludag University, Bursa, Turkey.
  • Ozdemir M; Department of Dermatology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Balevi A; Department of Dermatology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Kocatürk Göncü E; Department of Dermatology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Altunay I; Department of Dermatology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
  • Gönül M; Department of Dermatology, Diskapi Yildirim Beyazit Training and Research Hospital, Istanbul, Turkey.
  • Ergin C; Department of Dermatology, Ankara Medical Park Hospital, Ankara, Turkey.
  • Ertam I; Department of Dermatology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Erdogan HK; Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Bilgin M; Department of Statistics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Mustafa Teoman E; Department of Dermatology, Ada Tip Hospital, Sakarya, Turkey.
Acta Dermatovenerol Alp Pannonica Adriat ; 27(3): 121-126, 2018 09.
Article en En | MEDLINE | ID: mdl-30244261
Asunto(s)
Buscar en Google
Imprimir
XML
PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Omalizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Acta Dermatovenerol Alp Pannonica Adriat Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Turquía
Buscar en Google
Imprimir
XML
PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Omalizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Acta Dermatovenerol Alp Pannonica Adriat Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Turquía